Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-27

Clinical Trial Update: Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares the efficacy and safety of Tiropramide and Octylonium for treating Irritable Bowel Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Octylonium (Octylonium)
  • Tiropramide (Tiropramide)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: UNKNOWN